Anti-PD-L1 Anticorps (A323290)

Nom du produit
Atezolizumab Biosimilar - Anti-PD-L1 Antibody - Low endotoxin, Azide free
Description du produit
Recombinant humanized monoclonal antibody to PD-L1.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivité
Human, Cynomolgus Macaque
Hôte
Humanized
Clonalité
Monoclonal
Isotype
IgG1
Chaînes légères
kappa
Conjuguer

Unconjugated

Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Masse moléculaire
This antibody has a predicted MW of 145 kDa.
Pureté
> 95% (by SDS-PAGE and SEC-HPLC).
Forme du produit
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Stockage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonymes
B7 H, B7 H1, B7 homolog 1, B7-H1, B7H, B7H1, CD 274, CD274, CD274 antigen, CD274 molecule, MGC142294, MGC142296, OTTHUMP00000021029, PD L1, PD1L1_HUMAN, PDCD1 ligand 1, PDCD1L1, PDCD1LG1, PDL 1, PDL1, Programmed cell death 1 ligand 1, Programmed death ligand 1, RGD1566211
Avertissement
Ce produit est uniquement destiné à la recherche. Il n'est pas destiné à un usage diagnostique ou thérapeutique.

Produits alternatifs à Anti-PD-L1 Anticorps (A323290)

Haut